Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

NCT00223951 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

900

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

Interventions

DRUG: R89674 (generic name not yet established)

Sponsor

Vistakon Pharmaceuticals